Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Comment by deepoil0808on Sep 30, 2021 8:48am
122 Views
Post# 33942541

RE:RE:RE:RE:SAN FRANCISCO (CALIFORNIA) testing sites OVERWHELMED

RE:RE:RE:RE:SAN FRANCISCO (CALIFORNIA) testing sites OVERWHELMEDProof of Naked Shorting:

I provide you a link:     https://www.stockwatch.com/Quote/Detail?C:MEDV

Look at the bottom of the page, the transactions from July 2, 2021 to September 1, 2021, you will see identical trades matching trades made on the E-Neo Exchange and, U-Neo ATS, and the shakedown of paniced longs occurs on the O-Omega and M-TriAct exchange

For example on July 28, 2021:

1,084,394 shares trade on the E-Neo Exchange and, an equivalent amount of 1,084394 shares trade on the U-Neo ATS exchange.   These are pretend trades..  One naked selling to same long.   Then because of locking down the stock, paniced longs sell 65,000 on O-Omega and, 74,947 on M-TriAct exchange.   It is the broker who does this for you without your knowledge.   So real selling volume is 65,000 + 74,947 or 139,947 and, not the pretend 2,308,735.

They played this game up until September 2nd.

They finally let go of matching trades as frustration is set in with longs and, now they are just accumulating on E-Neo exchange.

The poster Knowsbest is part of this as the hedge funds he works for want to cover their naked shares before the stock soars.

So I caught them above with the link. 

For my target price of $ 1.50 per share, it is really based on SOARING DEMAND, trading at really 1x sales going forward, and this with shares circulating at 400 million shares.   Demand is exploding as we speak but that is nothing compared to the Biden law that will make tests mandatary for corporations with over 100 employees to get tested weekly.

It puts 100 million Americans in this category.   If we only get 100,000 of then we have $ 720 million in year revenue.

It is just HUGE and, any long selling now is doing so out of fear and ignorance.   There is no other way to phrase it. 
<< Previous
Bullboard Posts
Next >>